The Safety of Intravenous Ferric Gluconate Self Administered During Routine Home Hemodialysis
Identifieur interne : 002780 ( Main/Exploration ); précédent : 002779; suivant : 002781The Safety of Intravenous Ferric Gluconate Self Administered During Routine Home Hemodialysis
Auteurs : M. Utley [États-Unis] ; A. Grundy [États-Unis] ; T. Gehr [États-Unis]Source :
- Hemodialysis International [ 1492-7535 ] ; 2004-01.
Abstract
Home hemodialysis (HHD) patients are often inconvenienced when intravenous iron preparations are administered. Formerly, these patients received their medication in the clinic on an off‐dialysis day or during in‐center hemodialysis (HD). For the last 2 years, 5 patients in our HHD program have been receiving intravenous ferric gluconate during their routine HD session. Procedure: All patients were trained in the proper administration of ferric gluconate in‐center. No test dose was administered. Ferric gluconate was infused via the heparin infusion pump on their HD machine at a rate of 31.25 mg/h. Doses were of either 62.5 mg or 125 mg per session. K/DOQI guidelines for intravenous iron use were adhered to. TSATs greater than 25%, ferritin greater than 100 ng/mL and less than 800 ng/mL, and hemoglobin between 11 and 12 g% were the goals of therapy. Both loading doses (8 doses during sequential HD sessions) and maintenance doses every week or every other week were employed. Results: Over the last 2 years, 223 doses were administered at home. No serious reactions occurred during the course of therapy. One patient experienced minor nausea and vomiting during one dose, which was thought to be possibly related to the iron infusion. This patient subsequently received ferric gluconate again without difficulty. Conclusion: Ferric gluconate can be safely administered at home during HHD.
Url:
DOI: 10.1111/j.1492-7535.2004.0085bo.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000850
- to stream Istex, to step Curation: 000844
- to stream Istex, to step Checkpoint: 001252
- to stream Main, to step Merge: 002789
- to stream Main, to step Curation: 002780
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The Safety of Intravenous Ferric Gluconate Self Administered During Routine Home Hemodialysis</title><author><name sortKey="Utley, M" sort="Utley, M" uniqKey="Utley M" first="M." last="Utley">M. Utley</name></author><author><name sortKey="Grundy, A" sort="Grundy, A" uniqKey="Grundy A" first="A." last="Grundy">A. Grundy</name></author><author><name sortKey="Gehr, T" sort="Gehr, T" uniqKey="Gehr T" first="T." last="Gehr">T. Gehr</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:05A3F7BD4ACC59F33F40FEBE82CD76C6B87E518B</idno><date when="2004" year="2004">2004</date><idno type="doi">10.1111/j.1492-7535.2004.0085bo.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-X7NMTWZV-0/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000850</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000850</idno><idno type="wicri:Area/Istex/Curation">000844</idno><idno type="wicri:Area/Istex/Checkpoint">001252</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001252</idno><idno type="wicri:doubleKey">1492-7535:2004:Utley M:the:safety:of</idno><idno type="wicri:Area/Main/Merge">002789</idno><idno type="wicri:Area/Main/Curation">002780</idno><idno type="wicri:Area/Main/Exploration">002780</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">The Safety of Intravenous Ferric Gluconate Self Administered During Routine Home Hemodialysis</title><author><name sortKey="Utley, M" sort="Utley, M" uniqKey="Utley M" first="M." last="Utley">M. Utley</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>MCV/Gambro Mechanicsville Dialysis Unit, Virginia Commonwealth University Health System, Richmond, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Grundy, A" sort="Grundy, A" uniqKey="Grundy A" first="A." last="Grundy">A. Grundy</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>MCV/Gambro Mechanicsville Dialysis Unit, Virginia Commonwealth University Health System, Richmond, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author><author><name sortKey="Gehr, T" sort="Gehr, T" uniqKey="Gehr T" first="T." last="Gehr">T. Gehr</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>MCV/Gambro Mechanicsville Dialysis Unit, Virginia Commonwealth University Health System, Richmond, VA</wicri:regionArea><placeName><region type="state">Virginie</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Hemodialysis International</title><title level="j" type="alt">HEMODIALYSIS INTERNATIONAL</title><idno type="ISSN">1492-7535</idno><idno type="eISSN">1542-4758</idno><imprint><biblScope unit="vol">8</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="103">103</biblScope><biblScope unit="page" to="104">104</biblScope><biblScope unit="page-count">100</biblScope><publisher>Blackwell Science Inc</publisher><pubPlace>Oxford, UK; Malden, USA</pubPlace><date type="published" when="2004-01">2004-01</date></imprint><idno type="ISSN">1492-7535</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1492-7535</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Home hemodialysis (HHD) patients are often inconvenienced when intravenous iron preparations are administered. Formerly, these patients received their medication in the clinic on an off‐dialysis day or during in‐center hemodialysis (HD). For the last 2 years, 5 patients in our HHD program have been receiving intravenous ferric gluconate during their routine HD session. Procedure: All patients were trained in the proper administration of ferric gluconate in‐center. No test dose was administered. Ferric gluconate was infused via the heparin infusion pump on their HD machine at a rate of 31.25 mg/h. Doses were of either 62.5 mg or 125 mg per session. K/DOQI guidelines for intravenous iron use were adhered to. TSATs greater than 25%, ferritin greater than 100 ng/mL and less than 800 ng/mL, and hemoglobin between 11 and 12 g% were the goals of therapy. Both loading doses (8 doses during sequential HD sessions) and maintenance doses every week or every other week were employed. Results: Over the last 2 years, 223 doses were administered at home. No serious reactions occurred during the course of therapy. One patient experienced minor nausea and vomiting during one dose, which was thought to be possibly related to the iron infusion. This patient subsequently received ferric gluconate again without difficulty. Conclusion: Ferric gluconate can be safely administered at home during HHD.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Virginie</li></region></list><tree><country name="États-Unis"><region name="Virginie"><name sortKey="Utley, M" sort="Utley, M" uniqKey="Utley M" first="M." last="Utley">M. Utley</name></region><name sortKey="Gehr, T" sort="Gehr, T" uniqKey="Gehr T" first="T." last="Gehr">T. Gehr</name><name sortKey="Grundy, A" sort="Grundy, A" uniqKey="Grundy A" first="A." last="Grundy">A. Grundy</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002780 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002780 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:05A3F7BD4ACC59F33F40FEBE82CD76C6B87E518B
|texte= The Safety of Intravenous Ferric Gluconate Self Administered During Routine Home Hemodialysis
}}
| This area was generated with Dilib version V0.6.33. |  |